Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Hikma delivers a solid H1 performance and re-affirms expectations for strong growth in the second half Press Release, Financial Results 07 August 2025 Hikma delivers a solid H1 performance and re-affirms expectations for strong growth in the second half
- Hikma R&D - Innovating analytical research: Meet Raghad Saleh Story, Life at Hikma 28 July 2025 Hikma R&D - Innovating analytical research: Meet Raghad Saleh
- Hikma R&D - Innovating analytical research: Meet Saras Konar Story, Life at Hikma 17 July 2025 Hikma R&D - Innovating analytical research: Meet Saras Konar
- Hikma remains a constituent of the FTSE4Good Index Press Release, Corporate 16 July 2025 Hikma remains a constituent of the FTSE4Good Index
Related content